20-F Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 FY 2021

Filing Information

Form Type	20-F
Accession Number	`0001213900-22-014666`
Period End Date	20211231
Filing Date	20220324
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	f20f2021_collplantbio_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 36 Cash Flow Statement 113 Stockholders Equity 30

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	10.77M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.79M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	6.96M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.15M	USD	Point-in-time
Short term cash deposits	`ShortTermCashDeposits`	$30.15M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	10.77M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	6.96M	shares	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$13.00K	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$830.00K	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$270.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$424.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$239.00K	USD	Point-in-time
Inventories	`InventoryNet`	$1.08M	USD	Point-in-time
Inventories	`InventoryNet`	$1.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$45.09M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.68M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$181.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$213.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.95M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.11M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.73M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$82.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$243.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.17M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.14M	USD	Point-in-time
Total assets	`Assets`	$10.84M	USD	Point-in-time
Total assets	`Assets`	$51.22M	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$1.03M	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$798.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$440.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$519.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$32.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$207.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.94M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.39M	USD	Point-in-time
Derivatives liability	`DerivativeLiabilitiesNoncurrent`	$28.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.95M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.09M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.98M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.36M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2021 and December 31, 2020; issued and outstanding: 10,772,024 and 6,963,838 ordinary shares as of December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$4.66M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2021 and December 31, 2020; issued and outstanding: 10,772,024 and 6,963,838 ordinary shares as of December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$2.93M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalAndWarrants`	$75.55M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalAndWarrants`	$114.22M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.80M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.09M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$45.12M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$5.42M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$10.84M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$51.22M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$6.14M	USD	Annual
Revenues	`Revenues`	$15.64M	USD	Annual
Revenues	`Revenues`	$2.32M	USD	Annual
Cost of revenues	`CostOfRevenue`	$1.88M	USD	Annual
Cost of revenues	`CostOfRevenue`	$3.00M	USD	Annual
Cost of revenues	`CostOfRevenue`	$2.00M	USD	Annual
Gross Profit	`GrossProfit`	$3.13M	USD	Annual
Gross Profit	`GrossProfit`	$13.64M	USD	Annual
Gross Profit	`GrossProfit`	$439.00K	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$4.41M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$4.07M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$7.63M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.66M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$4.67M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$5.94M	USD	Annual
Total operating income (loss)	`OperatingIncomeLoss`	$-7.63M	USD	Annual
Total operating income (loss)	`OperatingIncomeLoss`	$-5.60M	USD	Annual
Total operating income (loss)	`OperatingIncomeLoss`	$65.00K	USD	Annual
Financial income (expenses), net	`NonoperatingIncomeExpense`	$-3.53M	USD	Annual
Financial income (expenses), net	`NonoperatingIncomeExpense`	$-175.00K	USD	Annual
Financial income (expenses), net	`NonoperatingIncomeExpense`	$172.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$237.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-11.16M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-5.77M	USD	Annual
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$0.02	USD	Annual
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.84	USD	Annual
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-2.23	USD	Annual
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$0.02	USD	Annual
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.84	USD	Annual
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-2.23	USD	Annual
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	4.99M	shares	Annual
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.89M	shares	Annual
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	9.97M	shares	Annual
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.97M	shares	Annual
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.89M	shares	Annual
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.99M	shares	Annual

Cash Flow Statement 113 line items

Line Item	Tag	Value	Unit	Period
Income (loss)	`ProfitLoss`	$5.77M	USD	Annual
Income (loss)	`ProfitLoss`	$11.16M	USD	Annual
Income (loss)	`ProfitLoss`	$-237.00K	USD	Annual
Depreciation	`Depreciation`	$773.00K	USD	Annual
Depreciation	`Depreciation`	$539.00K	USD	Annual
Depreciation	`Depreciation`	$660.00K	USD	Annual
Gains from Short term cash deposits	`GainLossOnSaleOfInvestments`	-	USD	Annual
Gains from Short term cash deposits	`GainLossOnSaleOfInvestments`	-	USD	Annual
Gains from Short term cash deposits	`GainLossOnSaleOfInvestments`	$151.00K	USD	Annual
Share-based compensation to employees and consultants	`SharebasedCompensationToEmployeesAndConsultants`	$1.67M	USD	Annual
Share-based compensation to employees and consultants	`SharebasedCompensationToEmployeesAndConsultants`	$1.60M	USD	Annual
Share-based compensation to employees and consultants	`SharebasedCompensationToEmployeesAndConsultants`	$1.12M	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$60.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$143.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$62.00K	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-28.00K	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$3.23M	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-40.00K	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$751.00K	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-560.00K	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-437.00K	USD	Annual
Decrease (increase) in inventories	`IncreaseDecreaseInInventories`	$374.00K	USD	Annual
Decrease (increase) in inventories	`IncreaseDecreaseInInventories`	$-181.00K	USD	Annual
Decrease (increase) in inventories	`IncreaseDecreaseInInventories`	$74.00K	USD	Annual
Decrease (increase) in other receivables	`IncreaseDecreaseInOtherReceivables`	$-35.00K	USD	Annual
Decrease (increase) in other receivables	`IncreaseDecreaseInOtherReceivables`	$185.00K	USD	Annual
Decrease (increase) in other receivables	`IncreaseDecreaseInOtherReceivables`	$-31.00K	USD	Annual
Decrease in operating right of use assets	`IncreaseDecreaseInOtherNoncurrentAsset`	$-442.00K	USD	Annual
Decrease in operating right of use assets	`IncreaseDecreaseInOtherNoncurrentAsset`	$-400.00K	USD	Annual
Decrease in operating right of use assets	`IncreaseDecreaseInOtherNoncurrentAsset`	$-237.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$236.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$228.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-35.00K	USD	Annual
Increase (decrease) in lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-229.00K	USD	Annual
Increase (decrease) in lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-337.00K	USD	Annual
Increase (decrease) in lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$145.00K	USD	Annual
Increase (decrease) in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-464.00K	USD	Annual
Increase (decrease) in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$740.00K	USD	Annual
Increase (decrease) in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$629.00K	USD	Annual
Decrease in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-175.00K	USD	Annual
Decrease in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-735.00K	USD	Annual
Decrease in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-1.01M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.50M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.70M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.45M	USD	Annual
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	$161.00K	USD	Annual
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	$82.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$437.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.49M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.43M	USD	Annual
Investment in short term deposits	`PaymentsToAcquireInvestments`	-	USD	Annual
Investment in short term deposits	`PaymentsToAcquireInvestments`	$30.00M	USD	Annual
Investment in short term deposits	`PaymentsToAcquireInvestments`	-	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$33.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-519.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-31.56M	USD	Annual
Proceeds from issuance of shares and warrants less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$5.44M	USD	Annual
Proceeds from issuance of shares and warrants less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$4.40M	USD	Annual
Proceeds from issuance of shares and warrants less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$32.74M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromWarrantExercises`	$89.00K	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromWarrantExercises`	$6.02M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromWarrantExercises`	$7.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	$20.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	$24.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	-	USD	Annual
Payments made for equipment on financing terms	`RepaymentsMadeForEquipmentOnFinancingTerms`	-	USD	Annual
Payments made for equipment on financing terms	`RepaymentsMadeForEquipmentOnFinancingTerms`	-	USD	Annual
Payments made for equipment on financing terms	`RepaymentsMadeForEquipmentOnFinancingTerms`	$17.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$38.76M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.41M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.46M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.75M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-505.00K	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$9.71M	USD	Annual
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.37M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$143.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$60.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-62.00K	USD	Annual
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.37M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$22.00K	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	-	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$355.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$23.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$97.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$557.00K	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	-	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	-	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	$2.02M	USD	Annual
Classification of warrants from liabilities to equity, net	`ProceedsFromIssuanceOfWarrants`	-	USD	Annual
Classification of warrants from liabilities to equity, net	`ProceedsFromIssuanceOfWarrants`	-	USD	Annual
Classification of warrants from liabilities to equity, net	`ProceedsFromIssuanceOfWarrants`	$1.33M	USD	Annual
Classification of issuance costs liability to equity	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	Annual
Classification of issuance costs liability to equity	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Classification of issuance costs liability to equity	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.79M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.15M	USD	Point-in-time
Restricted deposits (including long term)	`RestrictedDepositincludingLongTerm`	$226.00K	USD	Point-in-time
Restricted deposits (including long term)	`RestrictedDepositincludingLongTerm`	$193.00K	USD	Point-in-time
Restricted deposits (including long term)	`RestrictedDepositincludingLongTerm`	$180.00K	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`RestrictedCashAndCashEquivalents`	$3.53M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`RestrictedCashAndCashEquivalents`	$3.97M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`RestrictedCashAndCashEquivalents`	$13.37M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Issuance costs	`IssuanceOfOrdinarySharesAndWarrants`	$50.00K	USD	Annual
Issuance costs	`IssuanceOfOrdinarySharesAndWarrants`	$3.21M	USD	Annual
Issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$51.00K	USD	Annual
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.42M	USD	Point-in-time
Issuance of ordinary shares and warrants, net of issuance cost	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$32.79M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance cost	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$7.37M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance cost	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$4.40M	USD	Annual
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$69.00K	USD	Annual
Exercise of Warrants, net of issuance costs of $51, see note 9 - A(2)	`StockIssuedDuringPeriodValueOther`	$5.72M	USD	Annual
Classification of warrants from equity to liability, see note 2c	`ClassificationOfWarrantsFromEquityToLiability`	$-1.80M	USD	Annual
Classification of warrants from liability to equity, see note 9 - A(2)	`ClassificationOfWarrantsFromLiabilityToEquity`	$3.14M	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$89.00K	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00M	USD	Point-in-time
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$299.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.60M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.12M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.60M	USD	Annual
Net income (loss) for the period	`NetIncomeLoss`	$237.00K	USD	Annual
Net income (loss) for the period	`NetIncomeLoss`	$-11.16M	USD	Annual
Net income (loss) for the period	`NetIncomeLoss`	$-5.77M	USD	Annual
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.42M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.